Per Stal

Karolinska Institutet

Sweden

Research Interests

Explore related searches

Professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (15)

Sven Petersson

Karolinska Institutet

SWEDEN

View details

Anders Svensson Marcial

Karolinska Institutet

SWEDEN

View details

Jochen M Schwenk

KTH Royal Institute of Technology

SWEDEN

View details

Stergios Kechagias

Professor

Linköping University

SWEDEN

View details

Linnea Widman

Karolinska Institutet

SWEDEN

View details

Mattias Ekstedt

Linköping University

SWEDEN

View details

Yi-Hua Zhang

Karolinska Institutet

SWEDEN

View details

Hans Van Vlierberghe

Ghent University Hospital

BELGIUM

View details

Torkel Brismar

Karolinska Institutet

SWEDEN

View details

Magnus Holmer

Karolinska University Hospital

SWEDEN

View details

Stefano Romeo

SWEDEN

View details

Catarina Lindqvist

Karolinska University Hospital

SWEDEN

View details

Matthias Löhr

Karolinska Institutet

SWEDEN

View details

AMIR MARI

ISRAEL

View details

Ying Shang

Karolinska Institutet

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Per Stal

Research Interests

Explore related searches

Contact this professor

Articles (13)

Treatment patterns and clinical outcomes of patients with hepatocellular carcinoma—a cohort study of 1020 patients in Sweden

One-year follow-up of short-term dietary intervention for MASLD: sustained improvements in steatosis, weight and dietary intake

HCC-surveillance is associated with improved HCC-related mortality in patients with cirrhosis – a case-control study

MicroRNAs as Plasma Biomarkers of Hepatocellular Carcinoma in Patients with Liver Cirrhosis—A Cross-Sectional Study

Long-term major adverse liver outcomes in 1,260 patients with non-cirrhotic NAFLD

Forty years of successful national research collaboration in liver disease – the Swedish experience

A wide scan of plasma proteins demonstrates thioredoxin reductase 1 as a potential new diagnostic biomarker for hepatocellular carcinoma

Non-alcoholic fatty pancreas disease and pancreatic exocrine insufficiency: pilot study and systematic review

Time trends in mortality and life expectancy in 22,658 patients hospitalized with alcohol-associated cirrhosis: A nationwide cohort study

Effect of common genetic variants on the risk of cirrhosis in non‐alcoholic fatty liver disease during 20 years of follow‐up

Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial

Reply to: “Reduced steatosis and weight as a result of specific diets or the dietitian themselves”

Variation in textural parameters of hepatic lesions during contrast medium injection

Collaborators (15)

Sven Petersson

Anders Svensson Marcial

Jochen M Schwenk

Stergios Kechagias

Linnea Widman

Mattias Ekstedt

Yi-Hua Zhang

Hans Van Vlierberghe

Torkel Brismar

Magnus Holmer

Stefano Romeo

Catarina Lindqvist

Matthias Löhr

AMIR MARI

Ying Shang

Make your next move.